Sabra Health Care REIT, Inc. — Form 8-K
Filed July 21, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
Sabra entered into letters of intent to re-tenant all 26 Avamere properties: 22 to Cascadia Healthcare subsidiaries and 4 to an existing tenant. Combined annualized cash rent will increase ~30% from $41M to $53M (annualized), with transaction closing expected H2 2026. Separately, Sabra settled a $300M RCA mortgage for $200M (closed June 30, 2026), reducing leverage from 5.0x to 4.8x Net Debt/EBITDA pro forma. Full-year 2026 Normalized FFO guidance raised to $1.53–$1.55/share (7% midpoint growth vs. 2025) and Normalized AFFO to $1.59–$1.61/share (8% growth).
Why this rating
Re-tenanting 26 properties (significant portfolio concentration), achieving 30% rent uplift ($12M annual increase), and de-risking leverage materially strengthen fundamentals. Mortgage settlement at 33% discount is accretive. Combined, these represent ~1.5% of market cap in annual NOI improvement—material for a REIT but execution risk remains on Avamere transition completion.
See more from July 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.